Study warns that reducing therapy to automated AI responses risks serious harm to patients.
AI has issues like deceptive empathy, unfair bias, and poor crisis management in therapy settings.
Read moreAI Sycophancy
A new study shows what happens when chatbots put comfort over council.
Read morePsychedelics: Risks and Benefits
Public health professional and psychedelic harm reduction advocate Kristin Nash, whose college-aged son died while under the influence of psilocybin and LSD, argues that psychedelic risks must be made clear to the public.
Post-Psychedelic Difficulties
The findings suggest that while anxiety and panic are among the most disruptive, issues like existential struggle and diminished self-esteem tend to last the longest—often persisting for over a year.
Read moreAyahuasca, Risks and Benefits
UCLA psychiatry professor Charles Grob discusses ayahuasca's risks, his research on the substance, and the growing need for new ayahuasca studies.
Read morePsychedelics for Depression, Risks and Benefits
This article looks at the risks and benefits of psychedelics for treating depression.
Read morePsychedelics Tied to Higher Odds for Schizophrenia
Understanding Risks with Psychedelics
Check out this guide on how to reduce risks with psychedelics.
Read moreDid the Psychedelic Research Bubble Burst?
The psychedelic renaissance is now at a point of reckoning, and the extraordinary promise of these drugs to quickly and easily transform lives for the better is starting to look more like a fever dream.
Read moreRisks with Psychedelics
Researchers should anticipate and track adverse effects in psychedelics research, a group of Maryland-based scientists argue in a paper recently published in Psychedelic Medicine.
For years, the field has been focused on the potential benefits of psychedelics, but the scientists argue that it’s time to pay more attention to understanding the risks.
Adverse Effects
This research study looks at the adverse effects in studies of psychedelics and MDMA.
Read more